<html>
<head>
<title>Top Investors in Medtech Startups</title>
</head>
<body>
<h1>Top Investors in Medtech Startups</h1>
<table>
<tr>
  <th>Investors</th>
  <th>Amount</th>
  <th>Valuation</th>
  <th>Date of the funding round</th>
  <th>Type</th>
  <th>Phase</th>
  <th>Canton</th>
  <th>Company</th>
  <th>Gender CEO</th>
  <th>Confidential</th>
</tr>
<tr>
  <td>n.a.</td>
  <td>-1</td>
  <td>128.4505085</td>
  <td>2019-12-01T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>dacadoo AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Zeiss Ventures, SICTIC</td>
  <td>-1</td>
  <td>113.74</td>
  <td>2023-03-01T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>InSphero AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>n.a.</td>
  <td>9.8</td>
  <td>101.4</td>
  <td>2018-06-01T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>InSphero AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>private investor</td>
  <td>-1</td>
  <td>80.0061912</td>
  <td>2018-05-01T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>dacadoo AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>btov, SVC</td>
  <td>29.7</td>
  <td>74.9</td>
  <td>2018-05-01T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>Qvq AG (Ava AG)</td>
  <td>Female</td>
  <td>0</td>
</tr>
<tr>
  <td>Speedinvest, Walter Group, private investors</td>
  <td>10.7</td>
  <td>54.12152356</td>
  <td>2020-08-01T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>Bloom Diagnostic AG</td>
  <td>Female</td>
  <td>0</td>
</tr>
<tr>
  <td>Advent Life Sciences, Earlybird Health, Gilde Healthcare, strategic investor</td>
  <td>49.3</td>
  <td>47.69</td>
  <td>2024-03-04T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>VD</td>
  <td>Argá Medtech SA</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Verve Ventures, Wingman Ventures,  Zürcher Kantonalbank, Boundary Holding, Willi Miesch, other investors</td>
  <td>8.5</td>
  <td>35.12</td>
  <td>2021-09-01T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>Scewo AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>n.a.</td>
  <td>-1</td>
  <td>35.11837868</td>
  <td>2022-03-01T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>Scewo AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Chindex Medical Limited (Hong Kong), Yellowstone Holding, private investors</td>
  <td>14.5</td>
  <td>34.65</td>
  <td>2023-08-10T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>ZuriMED Technologies AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Belmondo, VP Venture Partners, HEMEX, OCCIDENT, Zürcher Kantonalbank, EFI</td>
  <td>14</td>
  <td>32.6</td>
  <td>2024-03-25T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>hemotune AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Dental Innovation Alliance</td>
  <td>-1</td>
  <td>31.14</td>
  <td>2024-01-19T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>Odne AG (Lumendo AG)</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Revere Partners (NY), NV Capital (LIE), Dental Innovation Alliance (DIA), Zürcher Kantonalbank, Plug&amp;Play, Hatcher, various family offices, angel investors</td>
  <td>4.8</td>
  <td>31.14</td>
  <td>2024-03-15T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>Odne AG (Lumendo AG)</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Sensirion, existing shareholders, private investors</td>
  <td>4</td>
  <td>29.00000029</td>
  <td>2020-12-01T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>BS</td>
  <td>MaxWell Biosystems AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>Ascend Capital Partnes, Kinled Holding, SICTIC</td>
  <td>11.1</td>
  <td>28.43</td>
  <td>2023-02-01T00:00:00</td>
  <td>VC</td>
  <td>Seed</td>
  <td>ZH</td>
  <td>NanoFlex Robotics AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>n.a</td>
  <td>7.7</td>
  <td>27.1533032</td>
  <td>2022-02-01T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>NEMIS TECHNOLOGIES AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>4FOX, SICTIC</td>
  <td>2.2</td>
  <td>24.21</td>
  <td>2024-11-14T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>Positrigo AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>RSBG Ventures</td>
  <td>9.2</td>
  <td>23.38</td>
  <td>2023-12-27T00:00:00</td>
  <td>VC</td>
  <td>Early Stage</td>
  <td>ZH</td>
  <td>Scewo AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
<tr>
  <td>European and US investors</td>
  <td>-1</td>
  <td>22.82458585</td>
  <td>2021-12-01T00:00:00</td>
  <td>VC</td>
  <td>Seed</td>
  <td>ZH</td>
  <td>Ancora.ai AG</td>
  <td>Female</td>
  <td>0</td>
</tr>
<tr>
  <td>EFI Lake Geneva, Start Angels, Zürcher Kantonalbank, Verve Ventures, Interconsult, Italian Investors Club, Excellis Holding, Business Angels</td>
  <td>4.5</td>
  <td>22.51</td>
  <td>2023-09-24T00:00:00</td>
  <td>VC</td>
  <td>Later Stage</td>
  <td>ZH</td>
  <td>HYLOMORPH AG</td>
  <td>Male</td>
  <td>0</td>
</tr>
</table>
</body>
</html>